US Stocks
/
Mind Medicine (MindMed) Inc. Share Price

Mind Medicine (MindMed) Inc. Share Price

NASDAQ: MNMD
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Mind Medicine (MindMed) Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Mind Medicine (MindMed) Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Mind Medicine (MindMed) Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-1.54
Revenue (TTM)
N/A
Return On Equity (TTM)
-45.01%
Profit Margin
N/A
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-630.17%

Mind Medicine (MindMed) Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025
RevenueN/AN/AN/AN/AN/A
Net Profit-$54.40M-$5.85M-$13.68M-$23.35M-$42.74M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A89.24%-133.75%-70.62%-83.07%

Mind Medicine (MindMed) Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232024
RevenueN/AN/AN/AN/A
Net Profit-$93.04M-$56.80M-$95.73M-$108.68M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A38.95%-68.55%-13.52%

About Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Mind Medicine (MindMed) Inc. Historical Returns

MonthOpenCloseChange %

MNMD Share Price FAQs

What is Mind Medicine (MindMed) Inc. share price today?

chevron-up
Mind Medicine (MindMed) Inc. share price today is $0.00 as on August 10, 2026 at 12:07 pm IST.

What is the 52 week high and 52 week low of Mind Medicine (MindMed) Inc. stock?

chevron-up
52 week high/low data for Mind Medicine (MindMed) Inc. is currently unavailable.

What is MNMD's net income for the last quarter?

chevron-up
MNMD's net income for the last quarter is -0.04B USD.

Can I buy MNMD shares in India?

chevron-up
Yes. You can buy MNMD in India by opening an international trading account.